It reported revenues of 38.41 million yuan in the first half of 2024 and a net loss of 903 million yuan, hit by falling ...

FTSE 100 pharma giants GSK and Astrazeneca may have escaped the worst of US President Donald Trump’s tariffs, according to a ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

Have you been searching for a stock that might be well-positioned to maintain its earnings-beat streak in its upcoming report ...

In a report released today, James Gordon from J.P. Morgan maintained a Sell rating on GlaxoSmithKline (GSK – Research Report), with a price ...

In a report released today, Emmanuel Papadakis from Deutsche Bank maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a ...

GSK exited Kenya in 2023 as part of its restructuring and now supplies its medicines and vaccines through a third-party distributor. Be part of an exclusive group of enthusiasts! Get fresh content ...

We recently published a list of the 7 Most Undervalued Biotech Stocks To Invest In. In this article, we are going to take a look at where GSK plc (NYSE: GSK) stands against the other most undervalued ...

GlaxoSmithKline has replaced the head of its ... and authorised generic sales to immediate generic competition. For GSK, the decision to replace Deirdre Connelly as president of GSK North America ...

Moderna stock has surged more than 20% this week after regulatory filings showed several executives bought shares on the open market. Glaxo (GSK) reported earnings 30 days ago. What's next for the ...

GSK says following the FDA approval, it will await the recommendation from ACIP before launching the product in the US. Key to Shingrix's success will be whether the US CDC decides to switch from ...